BEATHeartbeam Inc. Common Stock
0.4933USD+2.17%Mkt Cap: 27.80M $P/E: —3d ago
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facilit…
Industry Peers
Health Information Services$40.27BUSDP/E 44.0
$13.12BUSD
$11.65BUSDP/E 52.6
$8.84BUSDP/E 39.5
$8.48BUSD
$7.14BUSDP/E 10.8
$4.80BUSDP/E 35.7
$4.51BUSDP/E 30.2
$4.33BUSD
$2.70BUSDP/E 96.0
$1.62BUSDP/E 42.4
$1.47BUSD
$1.46BUSDP/E 35.7
$1.29BUSD
$1.18BUSDP/E 57.5
$1.16BUSD
$870.57MUSD
$844.16MUSDP/E 40.1
$748.70MUSDP/E 75.8
$736.36MUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
 HeartBeam, Inc. Q2 2026 Earnings Call Summary Moby summary of HeartBeam, Inc.'s Q2 2026 earnings call | ||
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... HeartBeam Inc (BEAT) progresses its regulatory pathway with a 510(k) pre-submission while expanding commercial agreements and extending its cash runway into 2027. | ||